$NHPAP
National Healthcare Properties, Inc.

2013 Q1 Form 10-Q Financial Statement

#000156103213000006 Filed on May 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $47.00K
YoY Change
Operating Profit -$47.00K
YoY Change
Interest Expense $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$47.00K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share -$5.29
Diluted Earnings Per Share -$5.29
COMMON SHARES
Basic Shares Outstanding 8.888K shares
Diluted Shares Outstanding 8.888K shares

Balance Sheet

Concept 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.000K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.179M
YoY Change
Total Liabilities & Shareholders Equity $3.000K
YoY Change

Cashflow Statement

Concept 2013 Q1
OPERATING ACTIVITIES
Net Income -$47.00K
YoY Change
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $0.00
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00
YoY Change
NET CHANGE
Cash From Operating Activities $0.00
Cash From Investing Activities $0.00
Cash From Financing Activities $0.00
Net Change In Cash $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Expenses
OperatingExpenses
62000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
638000 USD
CY2013Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
37000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 arct Common Stock Dividends Per Share Per Day Declared
CommonStockDividendsPerSharePerDayDeclared
0.00465753425
arct Initial Public Offering Subscriptions Required To Break Escrow Minimum
InitialPublicOfferingSubscriptionsRequiredToBreakEscrowMinimum
2000000 USD
CY2012Q4 arct Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest Units
LimitedLiabilityCompanyLlcOrLimitedPartnershipLpMembersOrLimitedPartnersOwnershipInterestUnits
90 shares
CY2013Q1 arct Reclassification Of Deferred Offering Costs
ReclassificationOfDeferredOfferingCosts
807000 USD
arct Reclassification Of Deferred Offering Costs
ReclassificationOfDeferredOfferingCosts
0 USD
CY2012Q4 arct Stock Available For Issuance Value Initial Public Offering
StockAvailableForIssuanceValueInitialPublicOffering
1700000000 USD
CY2013Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1182000 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
625000 USD
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-1117000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
200000 USD
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-1320000 USD
CY2012Q4 us-gaap Assets
Assets
810000 USD
CY2013Q1 us-gaap Assets
Assets
3000 USD
CY2013Q1 us-gaap Cash
Cash
3000 USD
CY2012Q4 us-gaap Cash
Cash
3000 USD
CY2012Q4 us-gaap Cash
Cash
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
3000 USD
CY2013Q1 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
0 USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12887 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8888 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12887 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8888 shares
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2013Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
200000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-62000 USD
CY2012Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
807000 USD
CY2013Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
0 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
15000 USD
CY2013Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
62000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
62000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
44000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
59000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
810000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-62000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-47000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-15000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
47000 USD
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
37000 USD
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
441000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 USD
CY2012Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200000 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q1 us-gaap Revenues
Revenues
0 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3000 USD
CY2012Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200000 USD
CY2013Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
-1179000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
185000 USD
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001561032
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
107333 shares
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
AMERICAN REALTY CAPITAL HEALTHCARE TRUST II, INC.

Files In Submission

Name View Source Status
0001561032-13-000006-index-headers.html Edgar Link pending
0001561032-13-000006-index.html Edgar Link pending
0001561032-13-000006.txt Edgar Link pending
0001561032-13-000006-xbrl.zip Edgar Link pending
archctii0331201310-qss.htm Edgar Link pending
arct-20130331.xml Edgar Link completed
arct-20130331.xsd Edgar Link pending
arct-20130331_cal.xml Edgar Link unprocessable
arct-20130331_def.xml Edgar Link unprocessable
arct-20130331_lab.xml Edgar Link unprocessable
arct-20130331_pre.xml Edgar Link unprocessable
ex101archctii0331201310-qss.htm Edgar Link pending
ex1021archctii0331201310-q.htm Edgar Link pending
ex103archctii0331201310-qss.htm Edgar Link pending
ex104archctii0331201310-qss.htm Edgar Link pending
ex106archctii0331201310-qss.htm Edgar Link pending
ex107archctii0331201310-qss.htm Edgar Link pending
ex108archctii0331201310-qss.htm Edgar Link pending
ex11archctii0331201310-qss.htm Edgar Link pending
ex14archctii0331201310-qss.htm Edgar Link pending
ex21archctii0331201310-qss.htm Edgar Link pending
ex311archctii0331201310-qss.htm Edgar Link pending
ex312archctii0331201310-qss.htm Edgar Link pending
ex32archctii0331201310-qss.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlogoex10-5.jpg Edgar Link pending
v344184archtiiex102aa.htm Edgar Link pending
v344184archtiiex105vsa.htm Edgar Link pending
v344184archtiiex31charter.htm Edgar Link pending
v344184archtiiex41lpa.htm Edgar Link pending